SWS Partners’s Acadia Healthcare ACHC Stock Holding History

SWS Partners’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-243	Closed	-$9K	–	103
2018 Q1	$9K	Hold	243	–	–	0.01%	264
2017 Q4	$8K	Buy	+243	New	+$8.42K	0.01%	273

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

SWS Partners's ACHC Position: Q2 2018 in Review

SWS Partners sold out of Acadia Healthcare (ACHC) in Q2 2018, closing a stake of 243 shares — an estimated $9K sold.

SWS Partners first reported a position in ACHC in Q4 2017 and held it in 2 quarters. The position peaked at $9K in Q1 2018. 251 funds tracked by Wall St. Rank hold ACHC as of Q2 2018.

SWS Partners reported no remaining Acadia Healthcare position as of Q2 2018 after selling out during the quarter.
SWS Partners sold 243 Acadia Healthcare shares in Q2 2018, an estimated $9K.
SWS Partners first reported a position in Acadia Healthcare in Q4 2017 and held it in 2 quarters.
SWS Partners's Acadia Healthcare position peaked at $9K in Q1 2018.
251 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2018.

Based on SWS Partners's 13F filing for Q2 2018, filed 13 Aug 2018.